Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)

China flag China · Delayed Price · Currency is CNY
5.55
+0.16 (2.97%)
Apr 30, 2026, 12:54 PM CST
24.44%
Market Cap 5.86B
Revenue (ttm) 2.37B
Net Income (ttm) -270.08M
Shares Out 1.09B
EPS (ttm) -0.25
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 41,970,830
Average Volume 36,492,702
Open 5.60
Previous Close 5.39
Day's Range 5.32 - 5.62
52-Week Range 4.20 - 6.74
Beta 0.44
RSI 58.50
Earnings Date Apr 29, 2026

About SHE:002793

Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, manufacture, and trading of drugs in China. The company provides antiviral, anti-infective, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers health care services. Luoxin Pharmaceuticals Group Stock Co., Ltd. was formerly known as Zhejiang Doyin Pump Industry Co., Ltd. and chan... [Read more]

Sector Healthcare
Founded 1998
Employees 3,196
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002793
Full Company Profile

Financial Performance

In 2025, SHE:002793's revenue was 2.27 billion, a decrease of -14.12% compared to the previous year's 2.65 billion. Losses were -288.58 million, -70.11% less than in 2024.

Financial Statements

News

There is no news available yet.